Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asian Institute of Gastroenterology is a leading super specialty hospital providing advanced clinical and surgical services in gastroenterology, hepatology, colorectal, pancreatic, and bariatric/metabolic disorders. Recent clinical research includes pioneering work in real-world immunotherapy for liver cancer using atezolizumab and bevacizumab, showing promising results such as 12.9% complete response and 25.8% partial response in unresectable hepatocellular carcinoma with a median overall survival of 21 months[5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asian Institute of Gastroenterology.